Structural basis for pore blockade of human voltage-gated calcium channel Cav1.3 by motion sickness drug cinnarizine

Cell Res. 2022 Oct;32(10):946-948. doi: 10.1038/s41422-022-00663-5. Epub 2022 Apr 27.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Calcium / metabolism
  • Calcium Channels, L-Type / chemistry
  • Cinnarizine*
  • Humans
  • Motion Sickness*

Substances

  • Calcium Channels, L-Type
  • Cinnarizine
  • Calcium